Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction

Area of Science:

• Molecular biology
• Biophysics
• Pharmacology

Background:

• G protein-coupled receptors (GPCRs) are crucial drug targets.
• Cholesterol modulates GPCR function and interaction.
• Beta-1 and beta-2 adrenergic receptors are highly homologous GPCR subtypes.

Purpose of the Study:

• To investigate subtype-specific cholesterol interactions with beta-1 and beta-2 adrenergic receptors.
• To elucidate general determinants of cholesterol binding to GPCRs.
• To reveal cholesterol binding pathways and sites within GPCRs.

Main Methods:

• All-atom molecular dynamics simulations (8-µs).
• Simulations of beta-1 and beta-2 adrenergic receptors embedded in a lipid bilayer.
• Analysis of cholesterol molecule accumulation and binding modes.

Main Results:

• Cholesterol molecules exhibit subtype-specific accumulation on beta-1 and beta-2 adrenergic receptors.
• Key factors for cholesterol binding (concave surface, charged/aromatic residues) are important but not indispensable.
• A cholesterol molecule's pathway into the consensus cholesterol motif (CCM) site was revealed, involving Trp4.50 side chain flipping.
• An alternative cholesterol-binding site in the helix 6 extracellular region of class-A GPCRs was suggested.

Conclusions:

• Cholesterol-GPCR interactions are subtype-specific, offering insights into physiological differences.
• Diverse combinations of factors dictate varied cholesterol binding modes.
• The study provides novel mechanistic insights into cholesterol binding to GPCRs, including a conserved binding pathway and an alternative binding site.